Literature DB >> 15741488

Aripiprazole in a patient vulnerable to side effects.

Sandra Dehning, Michael Riedel, Norbert Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15741488     DOI： 10.1176/appi.ajp.162.3.625

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

1.  Treatment strategies for tics in Tourette syndrome.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

2.  Aripiprazole for the treatment of Tourette's disorder.

Authors:  Prasad R Padala; S Faiz Qadri; Vishal Madaan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.

Authors:  Gholson J Lyon; Stephanie Samar; Rahil Jummani; Scott Hirsch; Arie Spirgel; Rachel Goldman; Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-12       Impact factor: 2.576

4.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

Review 5.  Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches.

Authors:  Norbert Müller
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

6.  Update on the role of antipsychotics in the treatment of Tourette syndrome.

Authors:  Daniel Huys; Katja Hardenacke; Pia Poppe; Christina Bartsch; Burak Baskin; Jens Kuhn
Journal:  Neuropsychiatr Dis Treat       Date:  2012-03-12       Impact factor: 2.570

7.  Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome.

Authors:  Sarah Gerasch; Ahmad Seif Kanaan; Ewgeni Jakubovski; Kirsten R Müller-Vahl
Journal:  Front Neurosci       Date:  2016-09-12       Impact factor: 4.677
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.